Collagen VI in cancer and its biological mechanisms

Peiwen Chen*, Matilde Cescon, Paolo Bonaldo

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

86 Scopus citations

Abstract

Collagen VI is a widely distributed extracellular matrix protein highly expressed in a variety of cancers that favors tumor growth and progression. A growing number of studies indicate that collagen VI directly affects malignant cells by acting on the Akt-GSK-3β-β-catenin-TCF/LEF axis, enhancing the production of protumorigenic factors and inducing epithelial-mesenchymal transition. Moreover, it affects the tumor microenvironment by increasing the recruitment of macrophages and endothelial cells, thus promoting tumor inflammation and angiogenesis. Furthermore, collagen VI promotes chemotherapy resistance and can be regarded as a potential biomarker for cancer diagnosis. Collectively, these findings strongly support a role for collagen VI as an important regulator in tumors and provide new targets for cancer therapies.

Original languageEnglish (US)
Pages (from-to)410-417
Number of pages8
JournalTrends in Molecular Medicine
Volume19
Issue number7
DOIs
StatePublished - Jul 2013
Externally publishedYes

Keywords

  • angiogenesis
  • cancer
  • chemotherapy resistance
  • collagen VI
  • inflammation
  • therapeutic target

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Fingerprint Dive into the research topics of 'Collagen VI in cancer and its biological mechanisms'. Together they form a unique fingerprint.

Cite this